This page is part of the FHIR Specification (v1.0.2: DSTU 2). The current version which supercedes this version is 5.0.0. For a full list of available versions, see the Directory of published versions
This is the narrative for the resource. See also the XML or JSON format.
AC followed by Paclitaxel + Trastuzumab Course 2
Name: Paclitaxel in Dose-dense Paclitaxel (Q14D) + Trastuzumab (Q7D)
Course: 2
Agent Protocols Options:
Paclitaxel 175 mg/m^2 IV over 3 hours D1 in cycles 1-4
Offset: None
Cycle length: Q14D x 4 cycles
Usage note: every effort has been made to ensure that the examples are correct and useful, but they are not a normative part of the specification.